Hepatic Encephalopathy 
Welcome,         Profile    Billing    Logout  

113 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hepatic Encephalopathy
ChiCTR2300070406: Clostridium butyricum live tablets prevents hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension: a randomized controlled study

Not yet recruiting
N/A
98
 
Clostridium butyricum 2 tablets/time 3 times/day; Lactulose 15ml/time, 3 times/day ;Lactulose 15ml/time, 3 times/day
Beijing Youan Hospital, Capital Medical University; Beijing Youan Hospital, Capital Medical University, 2022 Annual Incubation Program for Young and Middle-aged Talents of Beijing Youan Hospital, Capital Medical University
hepatic encephalopathy (HE), portal hypertension
 
 
NCT06201988: Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Not yet recruiting
N/A
500
US
Power Life Sciences Inc.
Hepatic Encephalopathy
01/26
01/27
ChiCTR2200066474: Application of MoCA-CFS comprehensive evaluation in predicting hepatic encephalopathy related hospitalization in Patients with cirrhosis in China

Recruiting
N/A
160
 
Not Applicable
The First Affiliated Hospital of Zhejiang University Medical College; The First Affiliated Hospital of Zhejiang University Medical College, The First Affiliated Hospital of Zhejiang University Medical College
hepatic encephalopathy
 
 
ChiCTR2300072189: Interventional Embolization of Spontaneous Portosystemic Shunts for the Management of Recurrent or Persistent Hepatic Encephalopathy: A Prospective, Non-Randomized, Cohort Study

Not yet recruiting
N/A
82
 
Interventional embolization combined with standard medical therapy ;Standard medical therapy
Mengchao Hepatobiliary Hospital of Fujian Medical University; Mengchao Hepatobiliary Hospital of Fujian Medical University, None
Cirrhosis Hepatic Encephalopathy
 
 
POEME, NCT05206487: Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study

Recruiting
N/A
30
Europe
Polydextrose
University Hospital, Toulouse, Société nationale française de gastro-entérologie
Hepatic Encephalopathy
06/25
06/25
NCT05669651: Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy

Active, not recruiting
N/A
100
RoW
Fecal Microbiota Transplantation
Hainv Gao
Hepatic Encephalopathy
06/25
12/25
NCT06040814: Microbiota, Sarcopenia, and Hepatic Encephalopathy Change in Cirrhotic Patients Before and After Rehabilitation

Recruiting
N/A
120
RoW
Rehabilitation Training
Chang Gung Memorial Hospital
Hepatic Encephalopathy
11/25
11/25
ChiCTR2200067135: A Multicenter, Prospective, Randomized Controlled Study to Explore the Efficacy and Safety of Fecal Microbiota Transplantation with Different Bacterial Doses in the Treatment of Recurrent Hepatic Encephalopathy

Not yet recruiting
N/A
100
 
Intestinal bacteria transplantation, 400 ml bacterial solution ;Intestinal bacteria transplantation, 800 ml bacterial solution
hulan (Hangzhou) Hospital; Shulan (Hangzhou) Hospital, the National Key Research and Development Program of China (2021YFA1301104)
hepatic encephalopathy
 
 
MindTheLiver, NCT05433948: Diagnosing Minimal Hepatic Encephalopathy

Enrolling by invitation
N/A
550
Europe
Simultaneous EEG and CRT, PSE test, Animal Naming Test
Hospital of South West Jutland, Regionshospitalet Silkeborg, Herlev Hospital, Aalborg University Hospital
Hepatic Encephalopathy, Liver Cirrhosis
12/26
12/31
VICIS, NCT03267615: - Vienna Cirrhosis Study

Recruiting
N/A
10000
Europe
Medical University of Vienna
Liver Cirrhosis, Portal Hypertension, Ascites, Variceal Hemorrhage, Hepatic Encephalopathy
12/26
12/27
ChiCTR2300069338: Exploration of the pathogenic mechanism of crosstalk between intestinal flora and metabolic network of MHE and study of the interference effect of rhubarb decoction

Not yet recruiting
N/A
270
 
Basic treatment + Enema with rhubarb decoction ;Basic treatment + Lactulose enema ;Basic treatment + No enema treatment ;No enema treatment ;No enema treatment
The First Affiliated Hospital of Guangxi University of Chinese Medicine; The First Affiliated Hospital of Guangxi University of Chinese Medicine, National Science and Nature Foundation funding
minimal hepatic encephalopathy
 
 
ACTRN12612000910808: Sevoflurane aggravate minimal hepatic encephalopath in cirrhosis patients

Recruiting
N/A
60
 
National Natural Science Foundation of China, National Natural Science Foundation of China
minimal hepatic encephalopathy, general anesthesia
 
 
NCT05466669: Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis

Recruiting
N/A
83
Europe
Johannes Gutenberg University Mainz
Hepatic Encephalopathy, Liver Cirrhosis
02/25
02/25
 

Download Options